Paolo Bernardeschi

449 total citations
22 papers, 285 citations indexed

About

Paolo Bernardeschi is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paolo Bernardeschi has authored 22 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paolo Bernardeschi's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). Paolo Bernardeschi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). Paolo Bernardeschi collaborates with scholars based in Italy and United Kingdom. Paolo Bernardeschi's co-authors include Giammaria Fiorentini, Maurizio Cantore, Stefano Guadagni, Gina Turrisi, Michele De Simone, G. Fiorentini, Francesco Bonechi, Petros Giovanis, P Dentico and Marco Vaira and has published in prestigious journals such as Journal of Clinical Oncology, Blood and CHEST Journal.

In The Last Decade

Paolo Bernardeschi

21 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paolo Bernardeschi Italy 9 137 109 61 60 58 22 285
M Anzà Italy 11 135 1.0× 67 0.6× 67 1.1× 103 1.7× 88 1.5× 26 358
Tsunehiro Yoshimura Japan 11 168 1.2× 50 0.5× 128 2.1× 63 1.1× 37 0.6× 35 293
Mario Ghosn France 10 73 0.5× 41 0.4× 150 2.5× 86 1.4× 55 0.9× 39 305
Fiona Hand Ireland 8 126 0.9× 42 0.4× 81 1.3× 79 1.3× 94 1.6× 17 430
Marc G. A. van Ijken Netherlands 9 120 0.9× 70 0.6× 56 0.9× 82 1.4× 67 1.2× 13 273
A. Astone Italy 9 233 1.7× 93 0.9× 69 1.1× 82 1.4× 52 0.9× 22 336
Yoshinari Matsuda Japan 11 132 1.0× 29 0.3× 81 1.3× 89 1.5× 62 1.1× 22 314
Mostefa Bennamoun France 10 136 1.0× 35 0.3× 77 1.3× 123 2.0× 55 0.9× 35 249
Sarah Morgan United States 6 231 1.7× 68 0.6× 53 0.9× 108 1.8× 150 2.6× 12 421
Zhengyin Liao China 12 104 0.8× 134 1.2× 76 1.2× 84 1.4× 117 2.0× 26 389

Countries citing papers authored by Paolo Bernardeschi

Since Specialization
Citations

This map shows the geographic impact of Paolo Bernardeschi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Bernardeschi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Bernardeschi more than expected).

Fields of papers citing papers by Paolo Bernardeschi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Bernardeschi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Bernardeschi. The network helps show where Paolo Bernardeschi may publish in the future.

Co-authorship network of co-authors of Paolo Bernardeschi

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Bernardeschi. A scholar is included among the top collaborators of Paolo Bernardeschi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Bernardeschi. Paolo Bernardeschi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernardeschi, Paolo, et al.. (2019). Sudden ventricular fibrillation and death during ibrutinib therapy—A case report. European Journal Of Haematology. 103(4). 442–443. 5 indexed citations
2.
Bernardeschi, Paolo, et al.. (2011). Targeted-Therapy in Advanced Renal Cell Carcinoma. Current Medicinal Chemistry. 18(11). 1651–1657. 33 indexed citations
3.
Bernardeschi, Paolo, et al.. (2010). Spontaneous Regression of Chronic Myeloid Leukemia during Pregnancy. Acta Haematologica. 124(4). 225–226. 1 indexed citations
4.
Conte, Alessandro Del, Paolo Bernardeschi, Fabio Ferla, et al.. (2010). Bisphosphonate-Induced Osteonecrosis of the Jaw 32 Months After Interruption of Zoledronate in a Patient With Multiple Myeloma. Journal of Oral and Maxillofacial Surgery. 68(5). 1179–1182. 6 indexed citations
5.
Bernardeschi, Paolo, Gina Turrisi, P Dentico, et al.. (2007). Thalidomide plus monthly high-dose dexamethasone in chemorefractory myeloma. Results of a phase II clinical study.. PubMed. 20(6A). 719–20. 3 indexed citations
6.
Fiorentini, Giammaria, et al.. (2007). A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia.. PubMed. 20(6A). 721–4. 52 indexed citations
7.
Fiorentini, Giammaria, et al.. (2006). Thyroid Metastases from Colorectal Cancer: No Longer a Rare Entity. Tumori Journal. 92(5). 465–466. 9 indexed citations
8.
Fiorentini, Giammaria, et al.. (2006). Imatinib mesylate induces responses in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy. Journal of Cancer Research and Therapeutics. 2(2). 68–68. 2 indexed citations
9.
Fiorentini, Giammaria, P Dentico, Maurizio Cantore, et al.. (2005). Capecitabine (XE) plus Irinotecan (IRI) as second-line treatment (XELIRI) for metastatic colorectal cancer (MCRC) in elderly patients: Feasibility and safety results from a Phase II study. Journal of Clinical Oncology. 23(16_suppl). 3676–3676. 7 indexed citations
10.
Fiorentini, Giammaria, Francesco Bonechi, Marco Vaira, et al.. (2004). Intra-Arterial Hepatic Chemoembolization in Liver Metastases from Neuroendocrine Tumors: A Phase II Study. Journal of Chemotherapy. 16(3). 293–297. 25 indexed citations
11.
Bernardeschi, Paolo, et al.. (2004). Trisomy 8 in Philadelphia‐negative cells during imatinib therapy. American Journal of Hematology. 77(1). 88–89. 4 indexed citations
12.
Fiorentini, Giammaria, Francesco Meucci, Francesco Bonechi, et al.. (2004). Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study.. PubMed. 24(3b). 2093–6. 36 indexed citations
13.
Bernardeschi, Paolo, et al.. (2004). Chemoresistant Myeloma: Phase II Clinical Study with Low-Dose Thalidomide Plus High-Dose Dexamethasone. Journal of Chemotherapy. 16(sup5). 90–93. 4 indexed citations
14.
15.
Rigacci, Luigi, Luca Nassi, Renato Alterini, et al.. (2004). Intensified Chop (CHOP14) Plus Rituximab in the Treatment of Elderly Patients with Aggressive and High Risk Non Hodgkin’s Lymphoma (NHL).. Blood. 104(11). 4577–4577. 1 indexed citations
16.
Rossi, Sandra, et al.. (2003). Thyroid metastases from colon cancer case report in a long term survivor.. PubMed. 22(4 Suppl). 243–5. 5 indexed citations
17.
Fiorentini, Giammaria, Paolo Bernardeschi, A Calcinai, et al.. (2003). Irinotecan Hepatic Arterial Infusion Chemotherapy for Hepatic Metastases from Colorectal Cancer: A Phase II Clinical Study. Tumori Journal. 89(4). 382–384. 37 indexed citations
18.
Bernardeschi, Paolo, et al.. (1995). Simultaneous presentation and following remission of chronic lymphocytic leukemia and multiple myeloma.. PubMed. 86(1). 25–25.
19.
Bernardeschi, Paolo, et al.. (1988). Recurrent Pleural Effusion as Manifesting Feature of Primitive Chest Wall Hodgkin's Disease. CHEST Journal. 94(2). 424–426. 10 indexed citations
20.
Bernardeschi, Paolo, et al.. (1984). Acute leukemia following acquired idiopathic sideroblastic anemia. A case report with description of clinical, morphological and cytochemical features.. PubMed. 69(1). 59–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Anzà Breakdown of academic impact, for papers by Tsunehiro Yoshimura Breakdown of academic impact, for papers by Mario Ghosn Breakdown of academic impact, for papers by Fiona Hand Breakdown of academic impact, for papers by Marc G. A. van Ijken Breakdown of academic impact, for papers by A. Astone Breakdown of academic impact, for papers by Yoshinari Matsuda Breakdown of academic impact, for papers by Mostefa Bennamoun Breakdown of academic impact, for papers by Sarah Morgan Breakdown of academic impact, for papers by Zhengyin Liao
Rankless by CCL
2026